Oculis Closes Phase III Eye Drop Trial Due to Third-Party Administrative Error https://www.biospace.com/drug-development/oculis-closes-phase-iii-eye-drop-trial-due-to-third-party-administrative-error.....
It seems that it is very likely that the CRO's mistake ruined the clinical trial. OPT also looks very similar, it is also ophthalmology!
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
60.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $738.7M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| OPT (ASX) Chart |
Day chart unavailable